Intravenous erythromycin dosages. 1979

P Dombrower

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P Dombrower
August 1978, Journal of pharmaceutical sciences,
P Dombrower
April 1987, American journal of hospital pharmacy,
P Dombrower
October 1986, Clinical pharmacy,
P Dombrower
July 1990, Journal of pediatric gastroenterology and nutrition,
P Dombrower
October 1985, Neurology,
P Dombrower
January 1980, The Journal of international medical research,
P Dombrower
September 1954, Bruxelles medical,
P Dombrower
September 1954, Proceedings of the staff meetings. Mayo Clinic,
P Dombrower
November 1989, DICP : the annals of pharmacotherapy,
P Dombrower
November 1986, American journal of hospital pharmacy,
Copied contents to your clipboard!